50% off Premium Yearly

TSE:CHE.UN
This summary was created by AI, based on 16 opinions in the last 12 months.
Chemtrade Logistics Income Fund (CHE.UN) has garnered attention from analysts due to its diverse portfolio of chemical products, particularly for water treatment, which provides relative stability as demand from municipalities remains steady. Despite the company's past challenges, recent improvements and strategic initiatives have led to a stronger outlook, with EPS beating expectations and a solid dividend yield. Experts highlight the company's good performance over the past year, with some encouraging signs of sustained growth and a potential for further stock appreciation. However, some analysts caution about high debt levels and the cyclical nature of the business, suggesting a watchful stance as market conditions evolve. Overall, the sentiment leans towards optimism, yet with an emphasis on careful monitoring of market movements and potential risks ahead.
Loves it. About 5% of his income fund. Still sees lots of long-term upside. New management doing all the right things such as selling some businesses and reducing debt. Increased dividend in January, payout ratio around 25-30%, 7.5% yield. Just reported strong results, putting it at high end of guidance for the year.
New sulfuric acid facility coming online in Ohio in 2025, will be best one in North America. Potential one in Arizona.
In chemicals that we need every day. Global customers -- most are water treatment (pretty stable), some pulp/paper and oil/gas. Down on revenue, but recent earnings and margins really good. Raised guidance again. Don't take a big position, try 1% to start. Big, fat yield of 6.9%.
(Analysts’ price target is $11.86)Raised guidance for second half of 2023. Really likes that it sells chemicals for water treatment, a utility-like business and a stable revenue stream. Very competitive in that market. With population growth comes increased water usage. Also chemicals to onshoring semiconductor industry. Fixed balance sheet, new management, firing on all cylinders.
Chemtrade posted strong Q1/24 results, and management is now guiding to the upper end of its 2024 guidance range. The operating segments are performing well and with a significantly stronger balance sheet relative to previous years, the Board has approved a 10% share buyback and the company is also considering strategic M&A opportunities. The balance sheet has improved a bit versus prior years as cash flow has grown. It is still cyclical, but we will give it kudos for its strong quarter and guidance. It is also priced well at 7X earnings. We note the company has cut its dividend in the past, however and at 5.5c is still not near its prior 10c level.
Unlock Premium - Try 5i Free